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The catalytic mechanism of glyceraldehyde
3-phosphate dehydrogenase from Trypanosoma cruzi
elucidated via the QM/MM approach†
Mauro Reis,ab Cla´udio Nahum Alves,*a Jeroˆnimo Lameira,a In˜aki Tun˜o´n,b
Sergio Martı´c and Vicent Moliner*c
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been identified as a key enzyme involved in
glycolysis processes for energy production in the Trypanosoma cruzi parasite. This enzyme catalyses the
oxidative phosphorylation of glyceraldehyde 3-phosphate (G3P) in the presence of inorganic phosphate
(Pi) and nicotinamide adenosine dinucleotide (NAD+). The catalytic mechanism used by GAPDH has
been intensively investigated. However, the individual roles of Pi and the C3 phosphate of G3P (Ps)
sites, as well as some residues such as His194 in the catalytic mechanism, remain unclear. In this study,
we have employed Molecular Dynamics (MD) simulations within hybrid quantum mechanical/molecular
mechanical (QM/MM) potentials to obtain the Potential of Mean Force of the catalytic oxidative
phosphorylation mechanism of the G3P substrate used by GAPDH. According to our results, the first
stage of the reaction (oxidoreduction) takes place in the Pi site (energetically more favourable), with
the formation of oxyanion thiohemiacetal and thioacylenzyme intermediates without acid–base
assistance of His194. Analysis of the interaction energy by residues shows that Arg249 has an important
role in the ability of the enzyme to bind the G3P substrate, which interacts with NAD+ and other
important residues, such as Cys166, Glu109, Thr167, Ser247 and Thr226, in the GAPDH active site.
Finally, the inhibition mechanism of the GAPDH enzyme by the 3-(p-nitrophenoxycarboxyl)-3-ethylene
propyl dihydroxyphosphonate inhibitor was investigated in order to contribute to the design of new
inhibitors of GAPDH from Trypanosoma cruzi.
Introduction
Chagas disease (American trypanosomiasis) is a protozoan
infection caused by the flagellate Trypanosoma cruzi,1 which is
endemic in 21 countries across Latin America. Chagas disease
causes more fatalities in the region each year than any other
parasite-borne disease, including malaria. According to the
Drugs for Neglected Diseases initiative (2010)2 there are
about 8 million cases, 14 000 deaths annually, and 667 000
disability-adjusted life years (DALYs). Chronic Chagas disease
results in significant disability with great social and economic
impact including unemployment and decreased earning ability.
In Brazil, losses of over $US 1.3 billion in wages and industrial
productivity were due to workers with Chagas disease. Patient
numbers are growing in non-endemic, developed countries
(e.g., Australia, Canada, Japan, Spain and United States) due
to increased migration of Latin American citizens unknowingly
carrying the parasite in their blood.
Although discovered in 1909 by the Brazilian sanitary doctor
Carlos Chagas, the disease still has no eﬀective treatment; the
drugs most commonly used to combat the disease, nifurtimox
and benznidazole, are not very eﬃcient and cause strong side
eﬀects.3 In search of targets more eﬃcient and more specific
for the disease, Opperdoes and Borst (1977)4 found that the
bloodstream from parasites of the Trypanosomatidae family
possesses a microbody like organelle called a glycosome in
which glycolysis occurs. Owing to the absence of functional
mitochondria, the bloodstream of Trypanosoma brucei is
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entirely dependent on glycolysis for its energy production.5
Biochemical studies indicate that the Trypanosoma cruzi axenic
amastigote intracellular form is highly dependent on the
catabolism of carbohydrates as an energy source.6 The high
dependence on glycolysis for energy production has made this
metabolic pathway and the enzymes involved as promising
targets for the design of anti-trypanosome drugs. Bakker and
co-workers7 identified glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH), phosphoglycerate kinase (PGK) and fructose-1,6-
bisphosphate aldolase (ALD) as key enzymes involved in
controlling the glycolytic flux of the parasite. Moreover, studies
on erythrocyte glycolysis concluded that a 95% deficiency in
these enzymes does not cause any clinical symptoms.7 The
inhibition of GAPDH leads to a significant reduction of glycolysis
in the parasite.7,8 The mechanism of the homotetrameric
GAPDH has been well studied.9–19 GAPDH catalyses the oxidative
phosphorylation of glyceraldehyde 3-phosphate (G3P) to 1,3-
bisphosphoglycerate (1,3-BPG) using nicotinamide adenosine
dinucleotide (NAD+) and inorganic phosphate (Pi). Experimental
kinetic studies published by Michels et al. (1996) show evidence
of the formation of the product 1,3-BPG. However, there is no
general agreement on the molecular mechanism. Schemes 1 and
2 show three possible mechanisms for the oxidoreduction stage
used by GAPDH involving the G3P substrate. In the first
proposed mechanism depicted in Scheme 1A, the G3P substrate
adopts a cis conformation and first binds to the Ps site of the
GAPDH active site, where the reaction is started with a nucleo-
philic attack of the Cys166 thiolate function on the aldehydic
carbon C1 of the G3P substrate, which leads to the formation of
a tetrahedron intermediate (hemithioacetal, HTA). A hydride
transfer assisted by His194 follows this step. In the next step, a
conformational change in the substrate is necessary to allow for
NADH release, while the C3P group of the substrate flips toward
the new Pi site.21,22 In the second proposed mechanism depicted
in Scheme 1B, the G3P substrate adopts a cis conformation,
however, this step takes place without the acid–base assistance
of His194. Finally, in the third proposed mechanism in
Scheme 2, the substrate G3P adopts the trans conformation,
where the G3P substrate first binds to the Pi site in the
oxidoreduction stage (see Schemes 1B and 2) and then flips
from Pi to the Ps site in the phosphorylation stage.18–20,23
Recently, crystallographic studies conducted by Castilho et al.
(2003)23 reported the refined glycosomal Trypanosoma cruzi
GAPDH in complex with an analogue of the thioacyl intermediate.
Their results are consistent with the experimental studies of
Corbier et al. (1994)20 and Yun, Park, Kim and Park (2000),24
which give strong experimental support for the generally accepted
flip–flop model of the catalytic mechanism in GAPDH.
A common feature of these structures is the presence of two
highly conserved cationic sites, which were assumed to be the
two phosphate binding sites; Ps is the C3 phosphate of G3P,
and Pi is the inorganic phosphate that were identified in the
GAPDH active site. The location of the Ps site in the three-
dimensional structure is conserved and independent of the
enzyme state. This Ps site is composed of the side chains of
residues Thr199, Thr197 and Arg249 and the 2-hydroxyl group
of the nicotinamide ribose of NAD (Fig. 1). On the other hand,
the location of the Pi site appears to vary depending on the
Scheme 1 Two possible reaction pathways for the oxidoreduction stage of Trypanosoma cruzi GAPDH. (A) The C3 phosphate first interacts with the Ps site. The
hydride transfer occurs through acid/base catalysis by His194 (see ref. 21 and 22). (B) The C3 phosphate first interacts with the Pi site. The hydride transfer occurs
without the assistance of His194 (see ref. 18–20 and 23). For both A and B, the reaction begins with a nucleophilic attack of the Cys166 thiolate function on the
aldehydic carbon C1 of the G3P substrate. This leads to tetrahedron intermediate formation of hemithioacetal (HTA) (A) or anion hemithioacetal (B) and then the
thioacylenzyme (TAE).
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presence and the nature of the bound ligands or source organ-
isms. Although the most common conformation is that origin-
ally found in the holoenzyme from H. americanus and Bacillus
stearothermophilus.15,18 An alternative conformation was first
observed in the holoenzyme from Thermotoga maritima and
Leishmania mexicana25,26 that generates a Pi site located closer
to the catalytic Cys149 residue and 3.0 Å away from the former
position, which has been called a new Pi site. Castilho et al.
(2003)23 reported a new location for the site Pi in the GAPDH of
Trypanosoma cruzi, where the phosphate group of a G3P analogue
forms hydrogen bonds with residues Thr226 and Arg249. In this
conformation, the phosphonate group is 3.35 Å to the position
previously described for the site of the phosphate in GAPDH
L. mexicana26 and 4.81 Å to the position described in Trypanosoma
brucei (Vellieux, Hajdu, and Hol, 1995).27 Ladame et al. (2003)28
reported a new location for the Pi site in GAPDH in T. cruzi. This
new binding site is very close to that previously identified in the 3D
structure of GAPDH in T. cruzi reported by Castilho et al. (2003).23
Thus, we must consider the diﬀerent locations of the binding
sites for Pi, which can be dependent on the organism. In our
particular case, we will consider these characteristics of T. cruzi
GAPDH (Fig. 1).
Scheme 2 Proposed catalytic mechanism.
Fig. 1 The location of the Pi and Ps sites in the three-dimensional structures of Trypanosoma cruzi GAPDH.
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Molecular Dynamics (MD) simulations with hybrid quantum
mechanics/molecular mechanics (QM/MM) potentials have
been previously performed to study enzymatic catalytic
mechanisms and protein–inhibitor interactions.29–33 In the
QM/MM method, a small part of the system (ligand/substrate
species) is described by quantum mechanics, while the protein
and solvent environment is represented by MM force fields.34,35
Recent reviews have addressed the use of the QM/MM approach
for biomolecular systems with an emphasis on enzymatic
reactions.35–38 QM/MM methods have also been used in drug
design.36–39 Recently, hybrid QM/MM methods have been
successfully employed to determine the first step of the catalytic
mechanism used by O-GlcNAcase involving substrate-assisted
catalysis.30 More recently, we have studied the inhibition
mechanism of GAPDH involving an iodoacetate (IAA) inhibitor
using the hybrid QM/MM MD.40
The analysis of free energy profiles has been performed to
gain insight into the pathway of the reaction and provide
theoretical support for the generally accepted catalytic mecha-
nism.29–33 Potential of Mean Force (PMF) from biased MD
simulations using an adequate distinguished reaction coordinate
may be employed to get the free energy profile of the transforma-
tion from reactants to products.37 In this report, we have investi-
gated the catalytic mechanism used by GAPDH of T. cruzi involving
oxidative phosphorylation of G3P to 1,3-BPG (Schemes 1 and 2)
from free energy profiles obtained in terms of two-dimensional
PMFs (2D PMFs) using QM/MM potentials. Particular attention has
been paid to the role of His194 in this mechanism and the main
site (Pi or Ps?) where the reaction begins. In addition, we have also
investigated the inhibition mechanism of the GAPDH enzyme
by the 3-(p-nitrophenoxycarboxyl)-3-ethylene propyl dihydroxy-
phosphonate inhibitor in order to understand the inhibition
mechanism and contribute to the design of new inhibitors. Finally,
analysis of interaction energies between the substrate (reactants, TS
and intermediate), cofactor, and protein was performed in order to
determine the role of key residues during the reaction.
Methods
The system
The crystal structures of GAPDH have been determined at
diﬀerent resolution from various organisms, among them
American lobster,15,49 humans,41,42 Bacillus stearothermo-
philus,18,22,50 Thermotoga maritima,25 Thermus aquaticus,43
Escherichia coli,44 Leishmania mexicana,26,45 Trypanosoma brucei27,46
and T. cruzi.23,47,48 In this study, the initial coordinates for
computational simulations were taken from the tetrameric crystal
structure of the T. cruzi GAPDH complex at 1.95 Å resolution (PDB
code 1K3T).48 All simulations were done using the fDynamo
library.51,52
The standard pKa values of ionizable groups can be shifted
by local protein environments.53 Therefore, an accurate assign-
ment of the protonation states of all these residues at pH 7 was
carried out by recalculating the standard pKa values of the
titratable amino acids using the empirical propKa program of
Jensen and co-workers (2005).54 According to this result,
most of all residues were found in their standard protonation
state. On the other hand, Polgar has suggested the existence of
a His194+/Cys166 ion pair,66 where the pKa corresponds to 8.2
and 5.5 for Cys166 and His194, respectively.66 Additionally,
under physiological conditions, a Cys166 residue shows
considerable nucleophilic reactivity in the active site of GAPDH.
In order to determine the existence of the His194+/Cys166
ion-pair, we have obtained a potential energy surface (PES)
using two coordinates that describe the proton transference
from Cys166 to His194 (Fig. S1, ESI†). The result shows
that the formation of the His194+/Cys166 ion-pair occurs
spontaneously, which is consistent with the results of Cartier
and co-workers.55
After adding the hydrogen atoms to the structure, a series of
optimization algorithms [steepest descent conjugated gradient
and L-BFGS-B]56 were applied. To avoid a denaturation of the
protein structure, all the heavy atoms of the protein and the
inhibitor were restrained by means of a Cartesian harmonic
umbrella with a force constant of 1000 kJ mol1 Å2. After-
wards, the system was fully relaxed, but the peptidic backbone
was restrained with a lower constant of 100 kJ mol1 Å2. The
optimised protein was solvated with a water molecules sphere
of 80 Å radius using the principal axis of the protein–substrate
complex as the geometrical centre. Any water with an oxygen
atom lying in a radius of 2.8 Å from a heavy atom of the protein
was deleted. The remaining water molecules were then relaxed
using optimisation algorithms. Finally, 100 ps of hybrid QM/
MM Langevin-Verlet MD (NVT) at 300 K was used to equilibrate
the model. During MD, the atoms of the substrate, the nicoti-
namide ring and the adjacent ribose of NAD+ and a side chain
of His194+ and Cys166 residues (present in the active site)
were selected for treatment by QM, using the semiempirical
AM1 Hamiltonian,57 resulting in 59 atoms in the QM region.
The rest of the system (protein plus water molecules)
was described using the OPLS-AA58 and TIP3P59 force fields,
respectively, as implemented in the fDynamo library.51,52 To
saturate the valence of the QM/MM frontier, we used the link
atoms procedure, placing these link atoms between the Ca and
Cb atoms of the His194+ and Cys166 residues, and between the
C40 and C50 atoms of the ribose ring of NAD+. The final system
contains a total of 39 546 atoms. Due to the amount of degrees
of freedom, any residue 18 Å apart from any of the atoms of the
initial inhibitor was selected to be kept frozen in the remaining
calculations. Cut-oﬀs for the nonbonding interactions were
applied using a switching scheme within a range of radius of
14.5 to 18 Å. Afterwards, the system was equilibrated by means
of 600 ps of QM/MM MD at a temperature of 300 K.
The computed RMSD for the protein renders a value always
below 0.03 Å. Furthermore, the RMS of the temperature
along the diﬀerent equilibration steps was always lower
than 2.5 K, and the variation coeﬃcient of the potential
energy during the dynamics simulations was never higher
than 0.4%.
The potential energy surface (PES). The fDynamo library51,52
was used to explore diﬀerent PES as a function of interatomic
distances. In order to verify themechanism for the oxidoreduction
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stage proposed by Moniot et al. (2008),22 two antisymmetric
combinations of distances R1a–R2a and R3a–R4a were used
as distinguished reaction coordinates to generate the PES (see
Scheme 1A). G3P adopts a cis conformation and initially binds to
the active site with C3 phosphate in the Ps site, and R1a–R2a
corresponds to general acid–base catalysis by His194 at G3P and
R3a–R4a corresponds to coordinates hydride transfer to NAD+.
Another possibility was also studied with the intention of verifying
the participation of His194 in the oxidoreduction stage. In this
case, the PES was built with the R1 and R2–R3 distances (see
Schemes 1B and 2 oxidoreduction stage), where the substrate is
initially bound to the active site with the group C3P in the site Pi
and where the G3P can adopt two diﬀerent conformations (cis and
trans). In the cis conformation (see Scheme 1B), the carbonyl of
G3P points to the His194 and discards the coordinates of the
acid–base assistance His194 but considers a possible electrostatic
interaction of His194 with the carbonyl group of G3P. In the
trans conformation (see Scheme 2), the carbonyl group of the
G3P substrate points to the opposite side of the His194 preventing
or hindering the assistance acid–base or electrostatic interac-
tion of the carbonyl of G3P with this residue. R1 corresponds to
the nucleophilic attack of Cys166 on the C1 aldehydic group
of G3P, and R2–R3 corresponds to hydride transfer from
G3P to NAD+.
The Potential of Mean Force (PMF). In order to obtain the
PMF60,61 associated with the oxidative phosphorylation
reaction of G3P, the reaction coordinate was selected based
on conclusions of the pathway described in the PES. All PMFs
have been calculated using the weighted histogram analysis
method (WHAM) combined with the umbrella sampling
approach62,63 as implemented in fDynamo.51,52
To estimate the activation free energy from this quantity we
recovered one-dimensional PMF changes tracing a maximum
probability reaction path on the 2D-PMF surface and integrating
over the perpendicular coordinate (see ESI† and ref. 64 and 65
for more details). In constructing the 2D-PMF, the distinguished
reaction coordinates were R1 and R2–R3, as defined in Scheme 2
(oxidoreduction stage). A total of 12 simulations were performed
at diﬀerent values of R1 (12 simulations in a range from +1.7 to
+3.5 Å), with an umbrella force constant of 2800 kJ mol1 A1; in
addition, a total of 40 simulations were performed at diﬀerent
values of R2–R3 (40 simulations in a range from 2.0 to +2.0 Å),
also with an umbrella force constant of 2800 kJ mol1 A1. The
values of the variables sampled during the simulations were
then pieced together to construct a full distribution function
from which the 2D-PMF was obtained. On each window, 5 ps of
relaxation was followed by 10 ps of production with a time step
of 0.5 fs due to the nature of the chemical step involving a
hydride transfer.
The use of QM/MM calculations in the evaluation of the free
energy is commonly restricted to semiempirical Hamiltonians
due to the large amount of gradient vector evaluations. One way
to reduce the error associated with this quantum level of theory
is the inclusion of correction terms in the potential energy
function, particularly by means of interpolated corrections72 as
follows:
E = EAM1/MM + S(x1,x2)
where S accounts for a two-dimensional derivable spline func-
tion, which is the result of the gas-phase diﬀerence between a
high-level (HL) energy calculation for the QM subsystem and a
low-level (LL) one. In the present work, the correction term
accounts for the MP2/6-31G** level of theory (HL) and the
semiempirical AM1 Hamiltonian (LL). These calculations were
carried out using the Gamess-US (ver 11, 2008R1) program.73
Results and discussion
Role for His194 in a catalytic mechanism
A question not yet clarified is the role of the catalytic residue
His (His176 in Escherichia coli, which is equivalent to His194 in
T. cruzi) of GAPDH. The possible contribution of the His194
residue in the catalysis of GAPDH could be as: (1) a chemical
activator of the Cys166 thiol group reactivity, (2) a base catalyst
to favour the hydride transfer, and (3) a stabilizer of the
tetrahedral transition states.21 Soukri et al. (1989)17 and Polgar
(1975)66 have proposed that the His176 in the active site of
Escherichia coli GAPDH acts as a chemical activator. In a
theoretical study, Cartier et al. (1999)55 have found a strong
interaction through hydrogen bonding between the Cys149/
His176+ ion pair (Cys149 in Escherichia coli, which is equivalent
to Cys166 in T. cruzi). This ion pair could explain the deep loss
in activity when the Cys149 was replaced by Ser149, which is
always in neutral form.55 Some mutagenesis studies have
shown that His176 could act as a base in the hydride transfer-
ence from the tetrahedron transition state.15,17,21 The existence
of the Cys149/His176+ ion pair was validated through experi-
mental assays.17,21,66 A molecular mechanism describing the
oxidoreduction stage was presented by Moniot et al. (2008),22
where the C3P group of glyceraldehyde-3-phosphate could be
localised in the Ps site (see Scheme 1A). The proposed reaction
starts with an attack of Cys166 on the C1 atom of the substrate,
which leads to tetrahedron intermediate (hemithioacetal, HTA)
formation. The second step is assisted by His176, which acts as
a base where the hydride transference from the C1 atom of the
substrate to the C4 of the nicotinamide group of NAD+ takes
place (Scheme 1A). Then, in agreement with results reported by
Moniot et al. (2008)22 the function of His176 is in a general base
catalysis. In this study the catalytic residues His194 and Cys166
of T. cruzi are equivalent to residues His176 and Cys149 of
E. coli and Bacillus strearothermophilus.
Pi  Ps site
The GAPDH enzyme has two anion recognition sites, Pi and
Ps,15 and the main site where the catalytic mechanism could
start remains unclear.22,23 Some mutagenesis studies were
performed in order to clarify the molecular mechanism used
by GAPDH.17,20,21 Skarzynski et al. (1987)18 and Corbier et al.
(1994)20 have proposed that the C3P group of G3P would first
interact with the Pi site. In the next stage, the coenzyme
exchange probably leads to conformational isomerisation of
the acyl group with the C3 phosphate flipping from the Pi to Ps
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site. On the other hand, Didierjean et al. (2003)67 exploring a
mutation of Cys149 by Ala or Ser in Bacillus stearothermophilus
GAPDH, provided conclusions that the reaction could initiate
in the Ps site. Recently, Castilho et al. (2003)23 studying T. cruzi
GAPDH in complex with a covalently bound G3P analogue
structure have proposed that the first stage of the reaction
takes place in the Pi site. In addition, experimental results
generally support the flip–flop model of the GAPDH catalytic
mechanism, where the reaction initiates in the Pi site, then
changes to the Ps site.18,20,24
The PES
The catalytic mechanism of GAPDH has been investigated
through kinetics and crystallographic studies.18,20,22–24,67
Nevertheless, as mentioned, the individual role of Pi and Ps
sites in the catalytic events remains unclear. In order to
investigate the role of His194 in the first stage of the reaction
and determine the site (Pi or Ps) where the first stage of the
catalytic mechanism used by GAPDH takes place, we have
constructed potential energy surfaces (PESs)39 using AM1/MM
and combining coordinates. The first PES (Fig. 2) was obtained
through two antisymmetric combinations of distances R1a–R2a
and R3a–R4a (see Scheme 1A), which correspond to the proton
transference from the N1 atom of His194 to the O1 atom of
glyceraldehyde 3-phosphate (G3P) and the hydride transference
from the C1 atom of the hemithioacetal intermediate to the C4
atom of the nicotinamide group of NAD+, respectively. The R on
this PES (Fig. 2) corresponds to reactive G3P, the INT-M
corresponds to the tetrahedron intermediate (HTA) assisted
by His194 and the INT1 corresponds to the thioacylenzyme
intermediate and NADH. This first PES (Fig. 2) was obtained
with G3P in the Ps site showing two possible pathways; the first
with the energy barrier of 105.47 kJ mol1 did not lead to products,
and the second with the energy barrier of 194.24 kJ mol1 led to the
expected intermediate INT1.
Two PES were built with symmetric and anti-symmetric
combinations of the R1 and R2–R3 distances, where the
substrate is initially bound to the active site with the group
C3P in the site Pi and where the G3P can adopt two diﬀerent
conformations (cis and trans). The R1 corresponds to the
nucleophilic attack of Cys166 on the C1 aldehydic group of
G3P, and R2–R3 corresponds to hydride transfer from G3P to
NAD+. Fig. 3 shows the two surfaces obtained with the C3P
group of G3P in the Pi site and represented two possible
conformations (cis and trans for G3P, respectively, see Fig. 3A
and B). We have estimated the energy barrier of the substrate in
the cis conformation to be 143.5 kJ mol1 while the barrier for
the trans conformation would be 119.23 kJ mol1. The energy
values of the PES are summarized in the diagram shown in
Fig. 4. In accordance with these results, the reaction takes place
in the Pi site (energetically more favourable) in the trans
conformation and the general base catalysis by His194 does
Fig. 2 AM1/MM potential energy surfaces for the hypothetical reaction pathway oxidoreduction stage of Trypanosoma cruzi GAPDH (Scheme 1A). The R on this PES
corresponds to reactive G3P, the INT-M corresponds to tetrahedron intermediate HTA assisted by His194, and the INT1 corresponds to thioacylenzyme intermediate
and NADH.
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not lead to intermediate INT1 as expected in the reaction. These
conclusions are in agreement with previous studies that point
to the Pi site as the first site of interaction of the substrate
G3P,18–20 in trans conformation.24
Free-energy profiles for substrate G3P (first stage)
Castilho et al. (2003)23 proposed that (i) G3P binds to the Pi
binding site, positioning the carbonyl group to interact with the
positively charged nicotinamidium ring; (ii) hydride transfer to
a cofactor leads to a loss of charge interaction and displace-
ment of the reduced cofactor and (iii) the thioacyl intermediate
flips to the Ps binding site, and a new NAD+ molecule is now
stabilised through hydrogen bonding of the phosphate to
ribose and hydrophobic contacts. In this proposed mechanism,
the first step of the reaction starts with the attack of Cys166 on
the C1 aldehydic group of G3P. Therefore, we have used the Pi
binding site where the phosphate moiety of G3P interacts with
residues Arg249, Thr167, Ser247 and Thr226 (Fig. 1A) as a
starting point to explore the attack of Cys166 on the C1
aldehydic group and the hydride transfer from G3P to NAD+.
The values free-energy changes and barriers of the oxidoreduc-
tion mechanisms of GAPDH depicted in Fig. 5 can be used to
build the free-energy diagram shown in Fig. 6. The first 2D PMF
(Fig. 5A) was obtained using AM1/MM methods through
symmetric and anti-symmetric combinations of R1 and R2–R3
(see Scheme 2), respectively. The R1 corresponds to the nucleo-
philic attack of Cys166 on the C1 aldehydic group of G3P
Fig. 3 Two AM1/MM potential energy surfaces obtained with the C3 phosphate first interact with the Pi site and represented two possible conformations (cis and
trans for G3P, respectively (A and B), corresponding to the oxidoreduction stage of Trypanosoma cruzi GAPDH).
Fig. 4 AM1/MM energy diagrams a, b and c for mechanisms proposed for
formation of the thioacylenzyme (TAE): (a) G3P in the Ps site; (b) G3P in the Pi site
(cis conformation); (c) G3P in the Pi site (trans conformation).
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(trans conformation), R2–R3 corresponds to hydride transfer
from G3P to NAD+, as described in the section above. The
product of the reaction, the INT1 thioester intermediate on the
2D-PMF presented in Fig. 5A, can be obtained via a hydride ion
transfer from C1 of G3P to NAD+. In the TS structure, TS1 on
the 2D-PMF presented in Fig. 5A, the bond distance for R1
corresponds to 1.92  0.13 Å indicating advanced progress of
the nucleophilic attack of Cys166 on the C1. On the other
hand, the bond distance for R2 in the TS1 corresponds to
1.32  0.01 Å, while R3 corresponds to 1.43  0.09 Å, indicating
that hydride transfer from G3P to NAD+ was initiated;
therefore, we can conclude that hydride transfer from G3P to
NAD+ occurs after the nucleophilic attack of Cys166 on the C1.
Other average key distances obtained from the AM1/MM
2D-PMF are showed in Table 1. The free-energy barrier between
R and TS1, calculated using the AM1 semiempirical level in the
QM region is 123.29 kJ mol1. The Relative Free Energies found
for stationary states to the profile traced with the AM1/MM level
are provided in Table 2. Fig. 5B shows the second 2D-PMF
obtained using MP2/6-31G**/MM methods, with respect to the
same reaction coordinates described above and the key averaged
distances are provided in Table 3. The minimum energy pathway
is shown by the dashed line in Fig. 5B, where the formation of
the hemithioacetal anion intermediate (INT0) after the nucleo-
phile sulfur attack C1 of the substrate can be observed. In fact,
Baer, Brinkman and Brauman (1991)68 suggest that tetrahedral
adducts of this type are often minima on the reaction potential
surface.
Table 4 shows the Relative Free Energies obtained for the
oxireduction stage including 2D interpolated corrections
calculated at the MP2/6-31G**. The barrier from this INT0 to
TS1 involves hydride transfer from G3P to NAD+ corresponding
to 77.21 kJ mol1. These results are consistent with the experi-
mental data of Yun et al. (2000)24 and Castilho et al. (2003),23
who proposed the formation of an anion hemithioacetal
intermediate and thioacylenzyme intermediate. Recently, the
Fig. 5 2D PMF corresponding to the oxidoreduction stage of Trypanosoma
cruzi GAPDH. Fig. 5A was obtained using AM1/MM, and Fig. 5B was obtained
using MP2/6-31G**/MM.
Table 1 Averaged distances of key distances for R, TS1, INT1 structures (in Å).
Standard deviations computed during the last 10 ps are reported in brackets
(in Å) from AM1/MM 2D-PMF
Å R TS1 INT1
R1 3.34(0.05) 1.92(0.13) 1.77(0.08)
R2 1.09(0.10) 1.32(0.01) 2.32(0.03)
R3 3.94(0.07) 1.43(0.09) 1.08(0.05)
Table 2 Relative Free Energies for R, TS1 and INT1 structures obtained from the
2D-PMF(AM1/MM). Values are reported in kJ mol1
kJ mol1 R TS1 INT1
0 123.29 3.46
Table 3 Averaged distances of key distances for R, INT0, TS1, INT1 structures
(in Å). Standard deviations computed during the last 10 ps are reported in
brackets (in Å) from 2D-PMF (MP2/6-31G**/MM)
Å R INT0 TS1 INT1
R1 3.34(0.05) 2.37(0.04) 1.93(0.13) 1.77(0.08)
R2 1.09(0.10) 1.21(0.08) 1.32(0.01) 2.32(0.03)
R3 3.94(0.07) 2.03(0.62) 1.43(0.09) 1.08(0.05)
Table 4 Relative Free Energies for R, INT0, TS1 and INT1 structures obtained
from the 2D-PMF (MP2/6-31G**/MM). Values are reported in kJ mol1
kJ mol1 R INT0 TS1 INT1
0 13.18 90.39 32.88
Fig. 6 Free-energy diagrams for formation of the thioacylenzyme (TAE) in the Pi
site (trans conformation). (a) Obtained at the AM1/MM level; (b) obtained at the
MP2/6-31G**/MM level.
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crystal structure of the thioacylenzyme intermediate was
obtained by diﬀusion of the natural substrate within the
crystal of the holoenzyme in the absence of inorganic
phosphate by Moniot et al. (2008), this evidence supports the
results of PMFs.
Free-energy profiles for substrate G3P (second stage)
The second stage of the proposed catalytic mechanism used by
GAPDH begins with the coenzyme exchange step, which
could result from a conformational isomerization of the
thioacylenzyme intermediate of the C3P of GAP from the Pi to
Ps site. Then, the free Pi site of GAPDH could bind inorganic
phosphate.23 The molecular structure of all protonation states
of pyrophosphate has been described by Colvin, Evleth,
and Akacem (1995).69 In aqueous solution at physiological
pH (B7.4), orthophosphate exists largely as the deprotonated
ions HPO4
2. Therefore, we have used HPO4
2 as a starting
point to study the second stage of the mechanism used
by GAPDH.
Experimental data have shown that the second stage of the
catalytic mechanism used by GAPDH takes place in the Ps
site.18–20,23,24 In this report, we have used the thioacylenzyme
intermediate obtained from 2D-PMF as a starting point of the
reaction in the Ps site. After the Pi–Ps exchange and assigning
the Pi protonation state, a PMF (Fig. 7) was obtained using
AM1/MM methods through anti-symmetric combinations of
R4–R5 (see Scheme 2) coordinates, which correspond to phos-
phorolysis of the resulting thioester through the nucleophilic
attack of inorganic phosphate on the carbonyl group of the
thioacylenzyme (Fig. 7). The product of the reaction is 1,3-
biphosphoglycerate, P on the PMF (Fig. 7), completing the
reaction cycle. In the TS structure, TS2 (Fig. 7), the bond
distance for R5 corresponds to 1.82 Å indicating advanced
progress of the nucleophilic attack of the phosphate ion on
the C1, while the bond distance for R4 in the TS corresponds to
1.89 Å indicating bond breaking between C1 and S of Cys166
(Table 5). The energy barrier between INT1 and TS2, calculated
using the AM1 semiempirical level in the QM region is
81.81 kJ mol1.
The proposed mechanism of GAPDH T. cruzi for oxidative
phosphorylation substrate G3P is represented by snapshots
that were obtained on the PMFs are shown in Fig. 8.
Free-energy profiles for a G3P analogue
Recently, GAPDH analogues have been described as irreversible
inhibitors that are covalently bound at the active cysteine residue.23
The formation of a thioacyl enzyme analogue obtained through the
reaction between the active site cysteine residue and an activated
carbonyl group of the G3P analogue leads to an irreversibly bound
and stable complex.23 In order to understand the mechanism of
GAPDH inhibition, we carried out free-energy profiles for a G3P
analogue (3-(p-nitrophenoxycarboxyl)-3-ethylene propyl dihydroxy-
phosphonate). We have used the Pi binding site (R in Fig. 9) as a
starting point to explore the attack of Cys166 on the carbonyl
group of the analogue G3P. A PMF (Fig. 10) was obtained using
AM1/MM methods through anti-symmetric combinations of R4–
R5. The energy profiles along this reaction coordinate correspond
to the nucleophilic attack of Cys166 on the atom C1 of the
carbonyl group of the G3P analogue (3c). In the TS structure, TS
in Fig. 9, the bond distance for R4 corresponds to 1.93 Å indicating
advanced progress of the nucleophilic attack of Cys166 on the C1.
The energy barrier between R and TS in Fig. 10, calculated using
the AM1 semiempirical level in the QM region is 96.23 kJ mol1.
This barrier is significantly lower than observed for the substrate
(123.29 kJ mol1), which explains the inhibition mechanism of
GAPDH by the G3P analogue inhibitor.
Fig. 7 Plot AM1/MM energies for INT1, TS2 and P structures obtained from the PMFs for corresponding phosphorylation stage of Trypanosoma cruzi GAPDH. Values
are reported in kJ mol1.
Table 5 Averaged distances of key distances for INT1, TS2, P structures (in Å).
Standard deviations computed during the last 10 ps are reported in brackets
(in Å) from AM1/MM 1D-PMF
INT1 TS2 P
R4 1.77(0.08) 1.89(0.12) 3.10(0.10)
R5 2.68(0.13) 1.82(0.05) 1.32(0.08)
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Fig. 8 Proposed catalytic mechanism obtained from theoretical calculations.
Fig. 9 Map electrostatic potential (MEP) for a G3P analogue (3c). Surfaces derived from B3LYP/6-31G* calculations for the R, TS and P. The increase of negative
charges goes from blue (positive) to red (negative).
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Interaction energy
In order to gain insight into the protein–substrate interactions,
100 ps of AM1/MM MD were run for all substrate–protein
complexes appearing along the free energy profile (R, INT0,
TS1, INT1) constraining the corresponding distinguished reac-
tion coordinate. Averaged protein–substrate interaction ener-
gies by residues are displayed in Fig. 11, where positive values
correspond to unfavourable interactions while negative values
mean stabilisation interactions. Analysis of the results reveals
that Arg249 has a significant eﬀect on the ability of the enzyme
to bind the substrate/inhibitor, this confirms the important
role of the Arg residue of the catalytic site of GAPDH in the
stabilisation of negative charges of the C3P group of glycer-
aldehyde-3-phosphate. This result could explain the marked
decrease in the rate of the first steps of the reaction, which lead
to acylenzyme formation when the Arg is replaced by Leu as
described in the mutagenesis studies of Corbier et al. (1994).20
Other important residues interacting with R–protein, INT0–
protein, TS1–protein and INT1–protein complexes are NAD+,
Cys166, Glu109, Thr226, Ser247 and Thr167. The NAD+, Cys166
and Arg249 were proposed to stabilise the tetrahedron inter-
mediate and transition state formed during the reaction.23 The
weak interactions with His194 observed in the R–protein, INT0–
protein, TS1–protein and INT1–protein complexes suggest that
the role of His194 is not to stabilise the tetrahedron transition
state or intermediate formed, but could be limited to activating
the nucleophilicity of Cys166. The stability of possible INT0
could be explained by electrostatic interactions with key residues
in the active site, such as Cys166 and Thr167. The pattern of
interaction of the INT1–protein is close to the TS1–protein
but with a weak interaction of NAD+ for NADH. This loss
of interaction is important for displacement of the reduced
cofactor.23 In addition, the interaction with Arg249 is weaker
in the INT1–protein complex, which could be necessary for the
conformational change from the Pi to Ps site. Finally, the Asp210
Fig. 10 Free-energy profiles for a G3P analogue [3-(p-nitrophenoxycarboxyl)-3-
ethylene propyl dihydroxyphosphonate] were obtained using AM1/MM. Values
are reported in kJ mol1.
Fig. 11 Contributions of individual amino acids to substrate–protein interaction energies (in kJ mol1) computed for R, INT0, TS1 and INT1.
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has an unfavourable interaction with G3P, which is negatively
charged; on the other hand, Asp210 stabilises Arg249 through a
bridge salt in the absence of the substrate,47 which could be
important in the release of the reaction product.
Molecular electrostatic potential (MEP)
Fig. 9 and 12 show the MEP surfaces derived from B3LYP/3-
21G(d) using Gaussian calculations (Frisch, 2004)70 and Gauss-
View71 for the 3c inhibitor and substrate G3P, where the
nucleophilic regions (negative electronic potential) are shown
in red and the electrophilic regions (positive electrostatic
potential) are shown in blue. These surfaces correspond to an
isodensity value of 0.02 au. The reactive (R) displays large
negative regions around the C3P group matching the position
of Arg249 and Cys166 around the S atom, which is ready to
attack the C1 atom of G3P. The oxyanion at thiohemiacetal C1
of G3P (INT0) interacts with the NH of Cys166, which is
consistent with the distance observed between C1 of G3P and
N of Cys166 of 2.98 Å in E. coli.24 In addition, the tetrahedral
transition state (TS1) contains a large negative charge around
the oxygen at the C1 of G3P and could interact more tightly with
NH of Cys166 and Thr167 and the C2 hydroxyl group of G3P;
this points to the oxygen of the carboxamide group of the
nicotinamide ring that through a hydrogen interaction helps
stabilise the transition state, therefore, keeping the G3P in an
energetically more favourable trans conformation, as proposed
by Yun et al. (2000).24 The R, INT0, TS1 and INT1 structures
show that the nicotinamide ring becomes more negatively
charged during the reaction. This ring is more negative in the
INT1 structure, which suggests that hydride transfer to NAD+
leads to a loss of charge. The MEP of INT1 closely resembles the
transition state (TS1) showing the formation of an oxoanion in
this enzymatic reaction. Analysis of MEP (Fig. 9) reveals that the
3c inhibitor is likely the substrate (R) and displays large
negative (red) regions around the C3P group matching the
position of Arg249. In the TS and P structure of the 3c inhibitor,
a large negative region on Cys166 around the S atom is also
observed.
Conclusions
We have investigated the catalytic mechanism used by GAPDH
involving the G3P substrate from 2D-PMF surfaces obtained
through QM/MM MD calculations. The results show that the
first stage of the reaction is not assisted by His194 and takes
place in the Pi site. Our results reveal that the reaction may start
with the attack of Cys166 on the C1 atom of the substrate,
which leads to an intermediate similar to the intermediate
anion hemithioacetal (HTA) described by Yun et al. (2000)24
and Castilho et al. (2003).23 The second stage corresponds to
phosphorolysis via nucleophilic attack of the inorganic phos-
phate on the carbonyl group of the thioacyl enzyme. These
theoretical results are consistent with the flip–flop model for
this enzyme mechanism proposed from the experimental
results. In accordance with results of interaction energy by
residues, Arg249 has a crucial role in the ability of the enzyme
to bind the substrate, which interacts also with NAD+, Cys166,
Glu109, Ser247, Thr167 and Thr226 in the active site of GAPDH.
The MEP reveals a large negative region around the C3P group
matching the position of Arg249, which is consistent with the
results of interaction energies computed by residues. Finally,
the inhibition mechanism of GAPDH by the 3c inhibitor reveals
that the barrier for the inhibition reaction is lower than that
Fig. 12 Map electrostatic potential (MEP) surfaces derived from B3LYP/6-31G* calculations for R, INT0, TS1 and INT1. The increase of negative charges goes from blue
(positive) to red (negative).
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observed for a natural substrate. This result may explain the
potential of this inhibitor.
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